Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets
- 14 June 2020
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 19 (8), 102583
- https://doi.org/10.1016/j.autrev.2020.102583
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle InvolvementArthritis Care & Research, 2014
- Meta‐Analysis of Healing and Prevention of Digital Ulcers in Systemic SclerosisArthritis Care & Research, 2013
- Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assayArthritis Research & Therapy, 2013
- Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical featuresArthritis Research & Therapy, 2011
- Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialAnnals Of The Rheumatic Diseases, 2010
- Anti–U11/U12 RNP antibodies in systemic sclerosis: A new serologic marker associated with pulmonary fibrosisArthritis Care & Research, 2009
- The changing landscape of the clinical value of the PM/Scl autoantibody systemArthritis Research & Therapy, 2009
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008
- Changes in causes of death in systemic sclerosis, 1972-2002Annals Of The Rheumatic Diseases, 2007
- Clinical trials in systemic sclerosis: lessons learned and outcomesArthritis Research & Therapy, 2007